器官类药物作为一种工具,用于研究肠道中的恒常性和病理性免疫-上皮相互作用
Emma Højmose Kromann1, Ainize Peña Cearra1,2, Joana F Neves1
1Centre for Host Microbiome Interactions, King's College London, London, United Kingdom.
Clinical and experimental immunology
|March 29, 2024
概括
与免疫细胞共同培养的肠道有机体促进了对肠道免疫-上皮相互作用的理解. 这种模型有助于发现组织修复,平衡,以及炎症,感染和癌症等疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 有机物技术 有机物技术
背景情况:
- 肠道含有最大的免疫细胞群,这是由于不断暴露于抗原.
- 表皮-免疫相互作用对于肠道平衡,控制感染,免疫激活和修复至关重要.
- 传统的研究模型在研究这些复杂的相互作用方面存在局限性.
研究的目的:
- 审查在免疫学研究中与免疫细胞共同培养的肠道有机体的应用.
- 为突出了解肠道免疫-上皮相互作用的进展.
- 探索有机体在免疫学中转化方法的潜力.
主要方法:
- 肠道有机体与免疫细胞共同培养.
- 使用有机体来模拟肠道平衡和疾病状态.
- 在有机体系统中产生组织特异性免疫细胞.
主要成果:
- 器官回顾了关键的肠道细胞和建筑特征.
- 共同培养模型揭示了对上皮质维护和再生的免疫贡献.
- 器官类药物有助于研究疾病相关基因对肠道免疫环境的影响.
结论:
- 与免疫细胞共同培养的肠道器官是研究肠道免疫学的强大工具.
- 这种模型系统使得在健康和疾病中的上皮质-免疫交叉中取得了新的发现.
- 在胃肠病学和免疫学中,有机体对翻译研究有很大的潜力.
相关概念视频
01:20Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...